Atrium Therapeutics, Inc.
HealthcareNASDAQ:RNA · NASDAQ Global Select
Market Cap $212.62M Beta 0.42 P/E (TTM) -3.3
$12.37 -0.48%
-$0.06 today
52W Low $11.40High $16.77
Vol 0.10M · Avg 0.38M
EPS (TTM)-$3.78
Biotechnology
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Events
Change
-16.14%
Period High
$16.54
Period Low
$11.55
Latest
$12.37
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
No competitor data available.
What is the latest RNA filing?
The latest filing shown is 15-12G dated Mar 9, 2026.
How many recent filings does RNA have?
Intrinsic Alpha currently shows 20 recent filings for RNA.
Explore More
Continue the stock analysis
Jump to another research area for this company.
OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.